The purpose of the CTRC is to provide the resources necessary to facilitate translational, community-based, and multi-center clinical research projects at Meharry. We are expanding existing programs, nurturing new investigators, and encouraging full use of our services. We can conduct your study and execute your data collection. We are here to cultivate your scientific skill set and ensure you are on the road to independent research.
We are currently recruiting for COVID-19 Vaccine Trials. Please complete this form or call 615-327-6820 for information about volunteering.
Advancing our understanding of how the human body works when it is healthy and developing new, more effective vaccines and therapies requires clinical research on human beings. Unfortunately, many studies end prematurely, simply because there are not enough participants who qualify and the scientists conducting studies are unable to locate new participants.
If you would like to be contacted when we have a study relevant to your age, gender, family history, disease history, or other interests, please contact us at 615.327.6820. The CTRC can also help you sign up at ResearchMatch.org, a nationwide registry that matches volunteers with scientific studies. Member institutions and their scientists can now look to the registry for a ready source of potential volunteers.
If you have questions about what it means to be a research participant, please contact the Regulatory Affairs Unit at 615.327.5654 or irb@mmc.edu.
EMERGE (Electronic Medical Records and Genomics) Trial: Results provided to 500 African American participants enrolled for genomic testing
Nashville Early Diagnosis Lung Cancer Project: High risk participant screening for lung cancer for a period of 5 years
PREVENTABLE Trial: Role of STATINS in elderly (>75 years of age) and dementia and cardiovascular disease-free survival
COVID-19 Vaccine Trials: Meharry’s CTRC approved as a site to conduct COVID-19 vaccines: Received $1.5M from Novavax
Bayer and AMGEN trials: Completed 2020. Closed to accrual.
IGNITE (Implementing Genomics in Clinical Practice) Trials: GUARDD-US (Genomic testing to Understand and Address Renal Disease Disparity in US) enrolling African- American participants with hypertension and chronic kidney disease for APOL-1 gene testing.
Research Coordinator I
Clinical & Translational Research Center
Research Coordinator II/Nurse
Office for Research & Innovation
Clinical & Translational Research Center
Research Coordinator II/Pharmacist
Office for Research & Innovation
Clinical & Translational Research Center
Research Coordinator II/Nurse Practitioner
Clinical & Translational Research Center
Clinical & Translational Research Center
Manager, Community Outreach and Engagement
Office for Research & Innovation
Research Coordinator I
Office for Research & Innovation
Clinical & Translational Research Center
Research Coordinator I
Clinical & Translational Research Center
Research Coordinator II/Nurse
Office for Research & Innovation
Clinical & Translational Research Center
Executive Director, Precision Medicine & Health Equity Trials Design
Office for Research and Innovation
Clinical & Translational Research Center, Center for Women's Health Research
Research Coordinator II/Pharmacist
Office for Research & Innovation
Clinical & Translational Research Center
Research Coordinator II/Nurse Practitioner
Clinical & Translational Research Center
Clinical & Translational Research Center
Research Coordinator I
Office for Research & Innovation
Clinical & Translational Research Center
Increased ease of access to genetic counseling for low-income women with breast cancer using a point of care screening tool.
Smita K Rao, Kimberly A Thomas, Rajbir Singh, Eden Biltibo, Philip E Lammers, Georgia L Wiesner
Evaluation of the MC4R gene across eMERGE network identifies many unreported obesity-associated variants.
Bahram Namjou, Ian B Stanaway, Todd Lingren, Frank D Mentch, Barbara Benoit, Ozan Dikilitas, Xinnan Niu, Ning Shang, Ashley H Shoemaker, David J Carey, Tooraj Mirshahi, Rajbir Singh, Jordan G Nestor, Hakon Hakonarson, Joshua C Denny, David R Crosslin, Gail P Jarvik, Iftikhar J Kullo, Marc S Williams, John B Harley
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients.
Tian Zhang, Sarabjot Pabla, Felicia L Lenzo, Jeffrey M Conroy, Mary K Nesline, Sean T Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Vincent Giamo, Jonathan Andreas, Yirong Wang, Wiam Bshara, Katherine G Madden, Keisuke Shirai, Konstantin Dragnev, Laura J Tafe, Rajan Gupta, Jason Zhu, Matthew Labriola, Shannon McCall, Daniel J George, Pooja Ghatalia, Farshid Dayyani, Robert Edwards, Michelle S Park, Rajbir Singh, Robin Jacob, Saby George, Bo Xu, Matthew Zibelman, Razelle Kurzrock, Carl Morrison
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.
Sarabjot Pabla, Jeffrey M Conroy, Mary K Nesline, Sean T Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jacob Hagen, Vincent Giamo, Jonathan Andreas, Felicia L Lenzo, Wang Yirong, Grace K Dy, Edwin Yau, Amy Early, Hongbin Chen, Wiam Bshara, Katherine G Madden, Keisuke Shirai, Konstantin Dragnev, Laura J Tafe, Daniele Marin, Jason Zhu, Jeff Clarke, Matthew Labriola, Shannon McCall, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Arun Singavi, Ben George, Andrew Craig MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Lynn Dressler, Mark Steciuk, Oliver Binns, Deepa Kasuganti, Neel Shah, Marc Ernstoff, Kunle Odunsi, Razelle Kurzrock, Mark Gardner, Lorenzo Galluzzi, Carl Morrison
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors.
Jeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, Sean T Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Yirong Wang, Felicia L Lenzo, Wiam Bshara, Maya Khalil, Grace K Dy, Katherine G Madden, Keisuke Shirai, Konstantin Dragnev, Laura J Tafe, Jason Zhu, Matthew Labriola, Daniele Marin, Shannon J McCall, Jeffrey Clarke, Daniel J George, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Luis de la Cruz-Merino, Arun Singavi, Ben George, Alexander C MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Deepa Kasuganti, Neel Shah, Roger Day, Lorenzo Galluzzi, Mark Gardner, Carl Morrison